Skip to main content
logo
Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
16.90
-0.22 (-1.29%)
At close: Oct 28, 2025, 4:00 PM EDT
16.98
+0.08 (0.47%)
After-hours: Oct 28, 2025, 7:53 PM EDT

Adaptive Biotechnologies Operating Metrics

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020
Number of Clonoseq Tests Delivered
88.98K82.18K76.11K70.84K66.31K61.46K56.50K51.34K
Number of Clonoseq Tests Delivered Growth
34.19%33.72%34.71%37.98%44.41%48.98%53.23%54.67%

Revenue by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
MRD
171.28M156.62M145.53M136.14M123.34M113.94M102.74M100.08M
MRD Growth
38.87%37.46%41.65%36.03%29.33%25.53%17.90%32.40%
Immune Medicine
33.94M32.90M33.43M41.14M45.43M60.56M67.54M79.61M
Immune Medicine Growth
-25.29%-45.67%-50.50%-48.32%-51.79%-35.27%-31.20%-13.89%

Immune Medicine Revenue Breakdown

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Immune Medicine Service
19.39M20.54M19.98M23.27M23.06M22.42M24.96M28.66M
Immune Medicine Service Growth
-15.89%-8.37%-19.96%-18.79%-23.09%-29.43%-21.46%2.98%
Collaboration
14.55M12.36M13.45M17.87M22.37M38.15M42.58M50.95M
Collaboration Growth
-34.98%-67.59%-68.41%-64.93%-65.19%-38.27%-35.86%-21.15%

Adjusted EBITDA by Segment

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024
MRD
-14.87M-28.08M-41.22M
Immune
-23.56M-24.52M-26.01M

MRD Revenue Breakdown

Period EndingJun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Service
156.28M144.12M133.03M123.64M115.84M109.44M102.74M98.08M
Service Growth
34.91%31.69%29.48%26.06%24.07%24.69%26.61%37.00%
Regulatory Milestone
18.00M17.00M-14.50M10.50M10.50M----7.50M-7.00M13.00M-
Regulatory Milestone Growth
71.43%126.67%-107.14%-19.23%----------
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.